Search - tctmd.com

Displaying 541 - 560 of 2538

Sort: Relevancy | Date

News Daily News

EMA Investigating Suicidal Thinking With GLP-1 Drugs for Weight Loss

Michael O'Riordan

July 12, 2023

News Daily News

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

L.A. McKeown

July 11, 2023

News Daily News

Frail Patients Also Benefit From Intensive BP Lowering: SPRINT Analysis

Todd Neale

July 10, 2023

News Daily News

A Focus on ‘Protective Foods’ Could Turn the Tide of CVD and Death

L.A. McKeown

July 07, 2023

News Daily News

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

Michael O'Riordan

July 07, 2023

News Daily News

Arsenic Exposure Tied to Subclinical CVD in Kids

Todd Neale

July 05, 2023

News Daily News

LDL Control Remains Poor in CAD Patients: NHANES

Michael O'Riordan

July 05, 2023

News Daily News

Some Daylight for Vitamin D? New Analysis Hints at Small CVD Benefit

Michael O'Riordan

June 30, 2023

News Daily News

Over Decades, Women Still Missing in NIH-Funded Trials for CVD

Caitlin E. Cox

June 30, 2023

News Conference News ADA 2023

Oral, Daily Semaglutide Cuts Pounds in Nondiabetic Patients: OASIS 1

Shelley Wood

June 29, 2023

News Conference News ADA 2023

Big Reductions in ASCVD Events With Bempedoic Acid in Primary Prevention

Michael O'Riordan

June 28, 2023

News Daily News

Method to Overcome CAC Score Variability Hones Risk Stratification

Todd Neale

June 26, 2023

News Daily News

AHA Scientific Statement Addresses Health Disparities in PAD

L.A. McKeown

June 23, 2023

News Daily News

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

Michael O'Riordan

June 23, 2023

News Daily News

Aspirin Use Ups Risk of Anemia in Elderly Patients: ASPREE

Michael O'Riordan

June 22, 2023

News Daily News

US Athlete’s Death Highlights Risk of Hypertensive Disorders of Pregnancy

Michael O'Riordan

June 19, 2023

News Daily News

Testosterone Doesn’t Cause CV Events in High-Risk Men With Hypogonadism

Caitlin E. Cox

June 16, 2023

News Daily News

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

Michael O'Riordan

June 14, 2023

News Daily News

Patients Most Vulnerable to CVD the Least Likely Use Wearable Devices

Caitlin E. Cox

June 13, 2023

News Daily News

Migraine With Aura Doesn’t Hone CV Risk Prediction in Middle-aged Women

Caitlin E. Cox

June 08, 2023

Advertisement

EMA Investigating Suicidal Thinking With GLP-1 Drugs for Weight Loss

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

Frail Patients Also Benefit From Intensive BP Lowering: SPRINT Analysis

A Focus on ‘Protective Foods’ Could Turn the Tide of CVD and Death

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

Arsenic Exposure Tied to Subclinical CVD in Kids

LDL Control Remains Poor in CAD Patients: NHANES

Some Daylight for Vitamin D? New Analysis Hints at Small CVD Benefit

Over Decades, Women Still Missing in NIH-Funded Trials for CVD

Oral, Daily Semaglutide Cuts Pounds in Nondiabetic Patients: OASIS 1

Big Reductions in ASCVD Events With Bempedoic Acid in Primary Prevention

Method to Overcome CAC Score Variability Hones Risk Stratification

AHA Scientific Statement Addresses Health Disparities in PAD

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

Aspirin Use Ups Risk of Anemia in Elderly Patients: ASPREE

US Athlete’s Death Highlights Risk of Hypertensive Disorders of Pregnancy

Testosterone Doesn’t Cause CV Events in High-Risk Men With Hypogonadism

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

Patients Most Vulnerable to CVD the Least Likely Use Wearable Devices

Migraine With Aura Doesn’t Hone CV Risk Prediction in Middle-aged Women

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content